CVS Health Corp’s filing revealed that its Director ROBBINS LARRY unloaded Company’s shares for reported $154.44 million on May 02 ’25. In the deal valued at $67.86 per share,2,276,068 shares were sold. As a result of this transaction, ROBBINS LARRY now holds 9,670,731 shares worth roughly $604.71 million.
Then, ROBBINS LARRY sold 1,323,932 shares, generating $89,249,945 in total proceeds. Upon selling the shares at $67.41, the Director now owns 8,346,799 shares.
Before that, ROBBINS LARRY sold 150,000 shares. CVS Health Corp shares valued at $10,000,710 were divested by the Director at a price of $66.67 per share. As a result of the transaction, ROBBINS LARRY now holds 8,196,799 shares, worth roughly $512.55 million.
Leerink Partners upgraded its CVS Health Corp [CVS] rating to an Outperform from a a Market perform in a research note published on February 13, 2025; the price target was increased to $75 from $55. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who increased its forecast for the stock in mid February from “a Neutral” to “an Overweight”. Edward Jones also remained covering CVS and has increased its forecast on January 30, 2025 with a “Buy” recommendation from previously “Hold” rating. Deutsche Bank revised its rating on December 03, 2024. It rated CVS as “a Buy” which previously was an “a Hold”.
Price Performance Review of CVS
On Friday, CVS Health Corp [NYSE:CVS] saw its stock jump 3.41% to $62.53. Over the last five days, the stock has lost -6.63%. CVS Health Corp shares have risen nearly 39.30% since the year began. Nevertheless, the stocks have risen 11.66% over the past one year. While a 52-week high of $72.51 was reached on 05/01/25, a 52-week low of $43.56 was recorded on 01/02/25. SMA at 50 days reached $66.40, while 200 days put it at $59.32.
Levels Of Support And Resistance For CVS Stock
The 24-hour chart illustrates a support level at 61.05, which if violated will result in even more drops to 59.57. On the upside, there is a resistance level at 63.35. A further resistance level may holdings at 64.16. The Relative Strength Index (RSI) on the 14-day chart is 41.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.48%. Stochastics %K at 15.41% indicates the stock is a buying.
